- Home
- ANIX vs MGF Comparison
ANIX vs MGF Comparison
Compare ANIX & MGF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIX
- MGF
- Stock Information
- Founded
- ANIX 1982
- MGF 1987
- Country
- ANIX United States
- MGF United States
- Employees
- ANIX N/A
- MGF N/A
- Industry
- ANIX Biotechnology: Pharmaceutical Preparations
- MGF Trusts Except Educational Religious and Charitable
- Sector
- ANIX Health Care
- MGF Finance
- Exchange
- ANIX Nasdaq
- MGF Nasdaq
- Market Cap
- ANIX 88.9M
- MGF 100.1M
- IPO Year
- ANIX 1987
- MGF N/A
- Fundamental
- Price
- ANIX $3.38
- MGF $3.07
- Analyst Decision
- ANIX Strong Buy
- MGF
- Analyst Count
- ANIX 3
- MGF 0
- Target Price
- ANIX $9.00
- MGF N/A
- AVG Volume (30 Days)
- ANIX 236.6K
- MGF 104.4K
- Earning Date
- ANIX 05-28-2025
- MGF 01-01-0001
- Dividend Yield
- ANIX N/A
- MGF 7.64%
- EPS Growth
- ANIX N/A
- MGF N/A
- EPS
- ANIX N/A
- MGF N/A
- Revenue
- ANIX N/A
- MGF N/A
- Revenue This Year
- ANIX N/A
- MGF N/A
- Revenue Next Year
- ANIX N/A
- MGF N/A
- P/E Ratio
- ANIX N/A
- MGF N/A
- Revenue Growth
- ANIX N/A
- MGF N/A
- 52 Week Low
- ANIX $2.07
- MGF $2.91
- 52 Week High
- ANIX $4.20
- MGF $3.46
- Technical
- Relative Strength Index (RSI)
- ANIX 57.87
- MGF 48.66
- Support Level
- ANIX $3.30
- MGF $3.05
- Resistance Level
- ANIX $3.80
- MGF $3.09
- Average True Range (ATR)
- ANIX 0.25
- MGF 0.03
- MACD
- ANIX 0.05
- MGF 0.00
- Stochastic Oscillator
- ANIX 61.47
- MGF 55.56
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About MGF MFS Government Markets Income Trust
MFS Government Markets Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income. The fund invests a majority of the net assets, including borrowings for investment purposes, in U.S. and foreign government securities. The company invest various sectors like U.S. Treasury Securities, Mortgage-Backed Securities, Investment Grade Corporates, Municipal Bonds, Non-U.S. Government Bonds, etc, out of which maximum revenue is gained from U.S. Treasury Securities.